Long QT Syndrome News and Research

RSS
Long QT syndrome (LQTS) is a disease that affects the normal heart rhythm and electrical activity. It may lead to sudden onset and dangerous arrhythmias (irregularities of heart rate and rhythm) which may be brought on by triggers like exercise or stress.
FDA grants Breakthrough Therapy status to Novartis' CTL019 for treatment of relapsed/refractory ALL

FDA grants Breakthrough Therapy status to Novartis' CTL019 for treatment of relapsed/refractory ALL

Scientists discover 23 new genes linked to heart rhythm

Scientists discover 23 new genes linked to heart rhythm

Genetic variant linked to sudden cardiac death leads to protein overproduction in heart cells

Genetic variant linked to sudden cardiac death leads to protein overproduction in heart cells

Bayer and Onyx announce Phase 3 trial evaluating use of NEXAVAR for patients with HCC after local ablation

Bayer and Onyx announce Phase 3 trial evaluating use of NEXAVAR for patients with HCC after local ablation

Copenhagen scientists study link between congenital arrhythmia and hypoglycemia

Copenhagen scientists study link between congenital arrhythmia and hypoglycemia

NEXAVAR tablets receive FDA approval for treatment of patients with thyroid cancer

NEXAVAR tablets receive FDA approval for treatment of patients with thyroid cancer

CDC and NIH collaborate to create Sudden Death in Young Registry

CDC and NIH collaborate to create Sudden Death in Young Registry

NHCS researchers discover potential cure for long QT syndrome 2

NHCS researchers discover potential cure for long QT syndrome 2

FDA grants Priority Review designation to sNDA for Nexavar tablets

FDA grants Priority Review designation to sNDA for Nexavar tablets

Bayer, Onyx submit sNDA to FDA, marketing authorization application to EMA for Nexavar tablets

Bayer, Onyx submit sNDA to FDA, marketing authorization application to EMA for Nexavar tablets

Bayer HealthCare to present new data on oncology portfolio at ASCO meeting

Bayer HealthCare to present new data on oncology portfolio at ASCO meeting

Bayer HealthCare: Patient enrollment underway in Phase III trial of Stivarga tablets for treatment of HCC

Bayer HealthCare: Patient enrollment underway in Phase III trial of Stivarga tablets for treatment of HCC

Study shows VATS-LCSD can help children with refractory cardiac arrhythmias

Study shows VATS-LCSD can help children with refractory cardiac arrhythmias

Mayo Clinic implements electronic warning system to identify patients at risk of QT-related deaths

Mayo Clinic implements electronic warning system to identify patients at risk of QT-related deaths

Researchers discover genetic variants of heart disorder in some cases of stillbirth

Researchers discover genetic variants of heart disorder in some cases of stillbirth

Investigators discover two new genes associated with severe early-onset disorders of heart rhythm

Investigators discover two new genes associated with severe early-onset disorders of heart rhythm

Researchers find new genetic differences in human hearts

Researchers find new genetic differences in human hearts

Bayer, Onyx announce data from Nexavar Phase 3 trial on RAI-refractory differentiated thyroid cancer

Bayer, Onyx announce data from Nexavar Phase 3 trial on RAI-refractory differentiated thyroid cancer

Exercise clue to long QT syndrome prognosis

Exercise clue to long QT syndrome prognosis

Computer simulation can predict risk of irregular heart rhythms and sudden cardiac death

Computer simulation can predict risk of irregular heart rhythms and sudden cardiac death